logo

Iterum Therapeutics Plc (ITRM)



Trade ITRM now with
  Date
  Headline
2/3/2021 11:44:12 PM Iterum Therapeutics Increases Size Of Offering And Purchase On A Firm Commitment Basis 34.8 Shares At $1.15/Shr
2/1/2021 7:12:26 AM Iterum Announces Collaboration With EVERSANA To Support Oral Sulopenem Launch
1/25/2021 7:14:23 AM Iterum Says FDA Accepted For Review NDA For Sulopenem Etzadroxil/probenecid
12/23/2020 7:09:55 AM Iterum Therapeutics' Michael Dunne Resigns As Chief Scientific Officer
12/7/2020 8:20:28 AM Iterum Announces Filing Of A U.S. National Phase Patent Application
9/30/2020 7:11:27 AM Iterum Therapeutics Announces Positive Pre-NDA Meeting With FDA For Sulopenem For Uncomplicated Urinary Tract Infections